More on NVCR
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $17.85 |
|
|||
| Open | $15.03 | ||||
| 52 Wk High | $28.95 | ||||
| 52 Wk Low | $5.95 | ||||
| Day High | $15.10 | ||||
| Day Low | $13.88 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 4,850,212 | ||||
- FreeCast surges premarket; Accenture, Novocure slide
- Novocure's TRIDENT trial misses primary endpoint in glioblastoma
- Form 8-K NovoCure Ltd For: Jun 18
- Novocure Announces Topline Data from the Phase 3 TRIDENT Trial Evaluating Earlier Use of Tumor Treating Fields Therapy in Newly Diagnosed Glioblastoma
- Form 8-K NovoCure Ltd For: Jun 03
- Form 4 NovoCure Ltd For: Jun 04 Filed by: Leonard Frank X
- Form 4 NovoCure Ltd For: Jun 03 Filed by: LEUNG GABRIEL
- Form 4 NovoCure Ltd For: Jun 03 Filed by: Stafford Kristin
- Form 4 NovoCure Ltd For: Jun 03 Filed by: Ocean Allyson J
- Form 4 NovoCure Ltd For: Jun 03 Filed by: Scannell Timothy J
Entities mentioned with nvcr
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- FDA | View Related Stories »
- 13G | View Related Stories »
- JPMorgan | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Show More...
